Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY518674 in mild hypertension
NCT00374855Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ly518674 in essential hypertension, sponsored by Eli Lilly and Company. Started Sep 2006; status: completed.
02
Drugs
ly518674
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00374855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374855.